Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Management of Phleboliths on Hip X-ray

Understanding Phleboliths

  • Phleboliths occur at sites of microshunts in venous malformations, and are composed of calcified thrombi that form within veins 1, 3

Diagnostic Approach

  • Radiographs may reveal calcifications (phleboliths) within soft tissue, suggesting a venous malformation, but radiography alone is not typically the initial imaging study when a vascular anomaly is suspected 1, 3
  • Phleboliths appear as rounded calcifications on x-ray and are a characteristic finding of venous malformations 1
  • Ultrasound (US) is the first-line follow-up imaging for superficial lesions, and can identify characteristic features of venous malformations including multiple anechoic spaces, echogenic phleboliths, and compressible soft tissue spaces 1, 4, 5
  • MRI without and with IV contrast is the most comprehensive evaluation for suspected venous malformations, typically showing a lobulated and often infiltrative soft tissue mass with T1 hypointense and T2 hyperintense signal, variable vascular flow voids, variable patterns of enhancement, and phleboliths 1, 2, 3
  • Dynamic 4-D MRA with IV contrast can detect the presence of arteriovenous microshunts in venous malformations, which are associated with phleboliths, with excellent sensitivity (83%) and specificity (95%) in differentiating low-flow from fast-flow vascular malformations 2, 6

Management Considerations

  • Management depends on the underlying vascular malformation and associated symptoms, and may involve interventional embolization/sclerotherapy and/or surgical intervention over years 1, 2, 6
  • The American College of Radiology recommends that phleboliths be evaluated with MRI for proper characterization and management 1, 2
  • CT imaging may provide further anatomic definition of venous malformations, aiding in visualizing phleboliths, thrombus, osseous changes, and soft tissue involvement 7